ABBV logo

AbbVie (ABBV) Return On Equity

Annual ROE

62.18%
+27.05%+77.00%

December 1, 2024

Summary

Performance

1-Year Change

+77%

3-Year Change

-23.14%

5-Year Change

+164.47%

15-Year Change

-43%

ABBV ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

88.8%
ABBV annual return on equity is higher than 88.8% of companies in Healthcare sector

High & Low

All-time High

187.45%
ABBV annual return on equity is currently -66.83% below its historical high of 187.45%

3-Year Low

35.13%
ABBV annual return on equity is currently +77.00% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2024
ABBV previous annual earnings announcement was published on Dec 1, 2024

Next Annual Earnings Report Date

N/A
ABBV next annual earnings announcement has not yet been scheduled

OtherABBVprofitabilitymetrics:

Annual Revenue

$56.33 B
ABBV annual revenue is $56.33 billion

Annual Net Income

$4.28 B
ABBV annual net profit is $4.28 billion

Annual EPS

$2.39
ABBV annual earnings per share is $2.39

Annual ROA

3.17%
ABBV annual return on assets is 3.17%

Quarterly ROE

61.64%
+2.72%+4.62%

December 1, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

-29.17%

5-Year Change

+164.11%

ABBV Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

89.95%
ABBV quarterly return on equity is higher than 89.95% of companies in Healthcare sector

High & Low

All-time High

594.47%
ABBV quarterly return on equity is currently -89.63% below its historical high of 594.47%

3-Year Low

36.83%
ABBV quarterly return on equity is currently +67.36% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 1, 2024
ABBV previous earnings announcement was published on Dec 1, 2024

Next Quarterly Earnings Report Date

Apr 25, 2025
ABBV next earnings announcement is scheduled for Apr 25, 2025

OtherABBVprofitabilitymetrics:

Quarterly Revenue

$15.10 B
ABBV quarterly revenue is $15.10 billion

Quarterly Net Income

-$22.00 M
ABBV quarterly net profit is -$22.00 million

Quarterly EPS

-$0.02
ABBV quarterly earnings per share is -$0.02

Quarterly ROA

3.04%
ABBV quarterly return on assets is 3.04%

ROE Formula

ROE =  Net Income
Shareholders Equity ✕ 100%

Annual ROE

62.18%
ABBV annual return on equity is 62.18%

Annual Net Income

$4.28 B
ABBV annual net profit is $4.28 billion

Annual Shareholders Equity

$3.33 B
ABBV annual stockholders equity is $3.33 billion

ABBV ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+77.0%0.0%
3 y3 years-23.1%-29.2%
5 y5 years+164.5%+164.1%

ABBV ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-23.1%+77.0%-30.1%+67.4%
5 y5-year-66.8%+164.5%-89.6%+120.2%
alltimeall time-66.8%+164.5%-89.6%+120.2%

AbbVie ROE History

DateAnnualQuarterly
Dec 2024
62.18%(+77.0%)
61.64%(+4.6%)
Sep 2024
-
58.92%(+11.0%)
Jun 2024
-
53.08%(+0.6%)
Mar 2024
-
52.78%(+43.3%)
Dec 2023
35.13%(-51.4%)
36.83%(-19.0%)
Sep 2023
-
45.46%(-22.3%)
Jun 2023
-
58.52%(+19.8%)
Mar 2023
-
48.86%(-34.2%)
Dec 2022
72.34%(-10.6%)
74.21%(-15.8%)
Sep 2022
-
88.16%(+1.3%)
Jun 2022
-
87.02%(-0.1%)
Mar 2022
-
87.08%(+3.3%)
Dec 2021
80.90%(-56.8%)
84.33%(+52.9%)
Sep 2021
-
55.16%(+15.0%)
Jun 2021
-
47.97%(-8.1%)
Mar 2021
-
52.18%(-37.8%)
Dec 2020
187.45%(-294.3%)
83.83%(-85.9%)
Sep 2020
-
594.47%(-294.5%)
Jun 2020
-
-305.63%(+193.3%)
Mar 2020
-
-104.22%(+8.4%)
Dec 2019
-96.45%(+43.2%)
-96.15%(+144.2%)
Sep 2019
-
-39.38%(-33.6%)
Jun 2019
-
-59.34%(-37.5%)
Mar 2019
-
-95.00%(-53.3%)
Dec 2018
-67.33%
-203.31%(-148.6%)
Sep 2018
-
418.37%(+133.2%)
Jun 2018
-
179.43%(+48.2%)
DateAnnualQuarterly
Mar 2018
-
121.11%(+25.1%)
Dec 2017
109.09%(-21.4%)
96.78%(-16.1%)
Sep 2017
-
115.42%(-3.2%)
Jun 2017
-
119.18%(-0.3%)
Mar 2017
-
119.57%(+1.8%)
Dec 2016
138.75%(-23.3%)
117.50%(-1.2%)
Sep 2016
-
118.92%(+2.3%)
Jun 2016
-
116.28%(-13.6%)
Mar 2016
-
134.66%(-8.7%)
Dec 2015
180.90%(+217.9%)
147.55%(+89.9%)
Sep 2015
-
77.68%(+37.8%)
Jun 2015
-
56.37%(+9.8%)
Mar 2015
-
51.36%(+20.4%)
Dec 2014
56.91%(-45.9%)
42.66%(-48.0%)
Sep 2014
-
82.02%(-15.3%)
Jun 2014
-
96.79%(-9.8%)
Mar 2014
-
107.36%(-6.7%)
Dec 2013
105.11%(+52.4%)
115.01%(+47.6%)
Sep 2013
-
77.94%(+11.9%)
Jun 2013
-
69.65%(+18.4%)
Mar 2013
-
58.84%(+21.6%)
Dec 2012
68.98%(+177.6%)
48.38%(+26.5%)
Sep 2012
-
38.25%(+36.3%)
Jun 2012
-
28.06%(-6.3%)
Mar 2012
-
29.96%(+4.1%)
Dec 2011
24.85%(-6.6%)
28.77%
Dec 2010
26.61%
-

FAQ

  • What is AbbVie annual return on equity?
  • What is the all time high annual ROE for AbbVie?
  • What is AbbVie annual ROE year-on-year change?
  • What is AbbVie quarterly return on equity?
  • What is the all time high quarterly ROE for AbbVie?
  • What is AbbVie quarterly ROE year-on-year change?

What is AbbVie annual return on equity?

The current annual ROE of ABBV is 62.18%

What is the all time high annual ROE for AbbVie?

AbbVie all-time high annual return on equity is 187.45%

What is AbbVie annual ROE year-on-year change?

Over the past year, ABBV annual return on equity has changed by +27.05% (+77.00%)

What is AbbVie quarterly return on equity?

The current quarterly ROE of ABBV is 61.64%

What is the all time high quarterly ROE for AbbVie?

AbbVie all-time high quarterly return on equity is 594.47%

What is AbbVie quarterly ROE year-on-year change?

Over the past year, ABBV quarterly return on equity has changed by 0.00% (0.00%)